By Michael Susin
The U.K. Competition and Markets Authority said it launched a merger inquiry regarding whether a deal for Roche Holding to buy certain companies linked to LumiraDx's point-of-care technology could hurt competition in the country.
The CMA said Friday that it has until July 19 to reach a phase one decision.
Both companies weren't immediately available for comments.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
05-24-24 0226ET